Mdeon is approved to ensure, in self-regulation, the prior visa procedure as stated in article 10, §3 of the Law on Medicinal products.

Mdeon was first approved by the Royal Decree of February 25, 2007 with retroactive effect on January 1st, 2007, date on which the visa procedure came into force.

In the light of its annual activity report and of an annual independent external audit, Mdeon’s approval was renewed by the King year after year:

The current approval is valid until 31 May 2021.